273 related articles for article (PubMed ID: 11693197)
1. Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus.
Rahimian R; Masih-Khan E; Lo M; van Breemen C; McManus BM; Dubé GP
Mol Cell Biochem; 2001 Aug; 224(1-2):29-37. PubMed ID: 11693197
[TBL] [Abstract][Full Text] [Related]
2. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients.
Auboeuf D; Rieusset J; Fajas L; Vallier P; Frering V; Riou JP; Staels B; Auwerx J; Laville M; Vidal H
Diabetes; 1997 Aug; 46(8):1319-27. PubMed ID: 9231657
[TBL] [Abstract][Full Text] [Related]
3. Diabetic KKAy mice exhibit increased hepatic PPARgamma1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones.
Bedoucha M; Atzpodien E; Boelsterli UA
J Hepatol; 2001 Jul; 35(1):17-23. PubMed ID: 11495036
[TBL] [Abstract][Full Text] [Related]
4. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.
Vidal-Puig A; Jimenez-Liñan M; Lowell BB; Hamann A; Hu E; Spiegelman B; Flier JS; Moller DE
J Clin Invest; 1996 Jun; 97(11):2553-61. PubMed ID: 8647948
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
[TBL] [Abstract][Full Text] [Related]
6. Relationships of PPARgamma and PPARgamma2 mRNA levels to obesity, diabetes and hyperinsulinaemia in rhesus monkeys.
Hotta K; Gustafson TA; Yoshioka S; Ortmeyer HK; Bodkin NL; Hansen BC
Int J Obes Relat Metab Disord; 1998 Oct; 22(10):1000-10. PubMed ID: 9806316
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.
Vidal-Puig AJ; Considine RV; Jimenez-Liñan M; Werman A; Pories WJ; Caro JF; Flier JS
J Clin Invest; 1997 May; 99(10):2416-22. PubMed ID: 9153284
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the peroxisome proliferator activated receptor gamma (PPARgamma) gene in HAIRAN syndrome with obesity.
Globerman H; Zauberman Y; Makarov T; Beamer BA; Yen CJ; Shuldiner AR; Harel C; Karnieli E
Clin Endocrinol (Oxf); 2000 Apr; 52(4):479-85. PubMed ID: 10762291
[TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle peroxisome proliferator- activated receptor-gamma expression in obesity and non- insulin-dependent diabetes mellitus.
Kruszynska YT; Mukherjee R; Jow L; Dana S; Paterniti JR; Olefsky JM
J Clin Invest; 1998 Feb; 101(3):543-8. PubMed ID: 9449686
[TBL] [Abstract][Full Text] [Related]
10. Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity.
Zhang J; Fu M; Cui T; Xiong C; Xu K; Zhong W; Xiao Y; Floyd D; Liang J; Li E; Song Q; Chen YE
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10703-8. PubMed ID: 15249658
[TBL] [Abstract][Full Text] [Related]
11. PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects.
Park KS; Ciaraldi TP; Abrams-Carter L; Mudaliar S; Nikoulina SE; Henry RR
Diabetes; 1997 Jul; 46(7):1230-4. PubMed ID: 9200661
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone (BRL49653), a PPARgamma-selective agonist, causes peroxisome proliferator-like liver effects in obese mice.
Edvardsson U; Bergström M; Alexandersson M; Bamberg K; Ljung B; Dahllöf B
J Lipid Res; 1999 Jul; 40(7):1177-84. PubMed ID: 10393202
[TBL] [Abstract][Full Text] [Related]
13. The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity.
Gao J; He J; Zhai Y; Wada T; Xie W
J Biol Chem; 2009 Sep; 284(38):25984-92. PubMed ID: 19617349
[TBL] [Abstract][Full Text] [Related]
14. Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice.
Haluzik M; Colombo C; Gavrilova O; Chua S; Wolf N; Chen M; Stannard B; Dietz KR; Le Roith D; Reitman ML
Endocrinology; 2004 Jul; 145(7):3258-64. PubMed ID: 15059949
[TBL] [Abstract][Full Text] [Related]
15. The orphan nuclear receptor small heterodimer partner is required for thiazolidinedione effects in leptin-deficient mice.
Tseng HT; Park YJ; Lee YK; Moore DD
J Biomed Sci; 2015 May; 22(1):30. PubMed ID: 25951943
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice.
Grefhorst A; van Dijk TH; Hammer A; van der Sluijs FH; Havinga R; Havekes LM; Romijn JA; Groot PH; Reijngoud DJ; Kuipers F
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E829-38. PubMed ID: 15941783
[TBL] [Abstract][Full Text] [Related]
17. A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643.
Edvardsson U; Alexandersson M; Brockenhuus von Löwenhielm H; Nyström AC; Ljung B; Nilsson F; Dahllöf B
Electrophoresis; 1999; 20(4-5):935-42. PubMed ID: 10344269
[TBL] [Abstract][Full Text] [Related]
18. Increased adipose tissue expression of Grb14 in several models of insulin resistance.
Cariou B; Capitaine N; Le Marcis V; Vega N; Béréziat V; Kergoat M; Laville M; Girard J; Vidal H; Burnol AF
FASEB J; 2004 Jun; 18(9):965-7. PubMed ID: 15059968
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiles of nondiabetic and diabetic obese mice suggest a role of hepatic lipogenic capacity in diabetes susceptibility.
Lan H; Rabaglia ME; Stoehr JP; Nadler ST; Schueler KL; Zou F; Yandell BS; Attie AD
Diabetes; 2003 Mar; 52(3):688-700. PubMed ID: 12606510
[TBL] [Abstract][Full Text] [Related]
20. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma.
Park KS; Ciaraldi TP; Lindgren K; Abrams-Carter L; Mudaliar S; Nikoulina SE; Tufari SR; Veerkamp JH; Vidal-Puig A; Henry RR
J Clin Endocrinol Metab; 1998 Aug; 83(8):2830-5. PubMed ID: 9709955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
